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Summary  Although  mitral  stenosis  is  mostly  due  to  rheumatic  fever,  other  etiologies,  such
as degenerative,  congenital,  drug-  or  radiotherapy-induced  mitral  stenosis,  are  emerging  and
need to  be  recognized  in  order  to  decide  the  best  therapeutic  options.  This  pictorial  reviewThree-dimensional describes  the  echocardiographic  features  of  these  different  anatomical  types  and  the  additional
value of  three-dimensional  echocardiography.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.Abbreviations: 2D, two-dimensional; 3D, three-dimensional; MS, mitral stenosis; MVA, mitral valve area; PMC, percutaneous mitral
commissurotomy; TEE, transoesophageal echocardiography; TTE, transthoracic echocardiography.
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Résumé  Bien  que  le  rhumatisme  articulaire  soit  de  loin  l’étiologie  la  plus  fréquente  du
rétrécissement  mitral,  les  autres  étiologies  comme  les  formes  dégénératives,  congénitales,
secondaires  à  la  radiothérapie  ou  à  certains  médicaments  voient  leur  incidence  augmenter  et
doivent être  reconnues  de  manière  à  permettre  un  traitement  approprié.  Dans  le  présent  arti-
cle, nous  décrivons  les  différentes  formes  échocardiographiques  de  rétrécissement  mitral  en
insistant sur  la  valeur  additionnelle  de  l’échographie  tridimensionnelle.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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presents  different  forms  of  rheumatic  MS  with  no,  unilateralackground
chocardiography  plays  a  major  role  in  the  evaluation  and
ecision-making  process  in  patients  with  mitral  stenosis
MS),  allowing  for  conﬁrmation  of  diagnosis,  evaluation  of
everity  and  choice  of  best  therapeutic  option  (feasibility
f  a  percutaneous  mitral  commissurotomy  [PMC]  or  surgi-
al  valve  replacement)  [1].  MS  is  mostly  due  to  rheumatic
ever  but  other  aetiologies  are  emerging  and  should  be
ecognized,  as  these  forms  are  usually  not  suitable  for
MC.  This  review  aims  to  present  the  different  aetiolo-
ies  of  MS,  their  echocardiographic  characteristics  and  the
otential  value  of  three-dimensional  (3D)  echocardiography
Table  1).
heumatic mitral stenosis
heumatic  MS  is  a  frequent  cause  of  valve  disease  in  devel-
ping  countries  and  remains  a  signiﬁcant  problem  in  Western
ountries  despite  the  striking  decrease  in  the  prevalence  of
heumatic  fever,  as  the  consequence  of  immigration  from
Table  1  Anatomical  characteristic  of  the  different  etiologica
Etiology  Commissures  
Rheumatic  mitral  stenosis
Native  valve  Fused  
Restenosis  due  to  commissural
refusion
At  least  partially  fused
Restenosis  due  to  valve  rigidity  At  least  one  commissur
completely  open
Degenerative  mitral  stenosis  Both  commissures  open
Post-radiation  mitral  stenosis  Both  commissures  open
Congenital  mitral  stenosis  Not  applicable  (absenc
of  commissure)
a
t
eeveloping  countries.  Thus,  according  to  the  Euro  Heart
urvey,  MS  still  accounted  for  12%  of  native  valvular  heart
isease  [2].  Commissural  fusion  is  the  main  mechanism  of
heumatic  MS.  Associated  lesions  are  chordal  shortening  and
usion,  and  leaﬂet  thickening.  Mobility  of  the  posterior  valve
s  almost  always  reduced  whereas  mobility  of  the  anterior
alve  is  often  preserved.  Later  in  the  disease  course,  super-
mposed  calciﬁcation  may  contribute  to  the  limitation  of
eaﬂet  motion.
Commissural  splitting  is  the  main  mechanism  by  which
he  mitral  valve  area  (MVA)  increases  after  PMC.  Commis-
ural  opening  should  be  evaluated  in  parasternal  short-axis
nd  has  been  shown  to  be  an  important  predictor  of  long-
erm  functional  outcome  after  PMC  [3].  The  achievement
f  a  complete  — ideally  bilateral  —  commissural  opening
s  thus  a  major  goal  during  PMC.  Our  group  has  previously
hown  that  3D  echocardiography  provides  a  better  assess-
ent  of  the  degree  of  commissural  opening  [4].  Fig.  1l  types  of  mitral  stenosis.
Mobility  Calciﬁcation
Restrictive  motion  of  the
posterior  valve
0  to  +++  (Possible)
 Restrictive  motion  of  the
posterior  valve
0  to  +++  (Possible)
e Restrictive  motion  of  the
posterior  valve
0  to  +++  (Possible)
 Normal  mobility  of  the  tip
of  both  leaﬂets
+++
Important
calciﬁcations  of  the
mitral  annulus  and
the  base  of  both
leaﬂets
 Absence  of  restrictive
motion  of  the  posterior
valve
+ to  +++
Highly  suggestive
calciﬁcations  of  the
mitral  aortic
membrane
e Normal  Usually  not
nd  bilateral  commissural  opening  in  two-dimensional  (2D)
ransthoracic  (TTE)  and  corresponding  3D  transoesophageal
chocardiography  (TEE)  views.
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Figure 1. Examples of rheumatic mitral valve oriﬁce in two-dimensional transthoracic echocardiography (top) and three-dimensional
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ttransoesophageal echocardiography (bottom), in a patient with no 
opening (C and D) and a patient with a bilateral commissural openi
In  addition,  real-time  3D-TTE  has  provided  accurate  MVA
measurements  similar  to  2D-TTE  and,  more  importantly,  has
improved  the  accuracy  of  planimetry  when  performed  by
non-experienced  operators  [4].  3D-TEE  also  provides  accu-
rate  and  reproducible  MVA  measurements,  similar  to  2D
planimetry  performed  by  experienced  operators,  and  could
be  considered  as  a  second-line  alternative  tool  for  the  evalu-
ation  of  MS  severity  in  patients  with  poor  echocardiographic
windows  or  for  teams  less  accustomed  to  evaluating  MS
patients  [5].
After  a  successful  PMC,  late  clinical  deterioration  may
eventually  occur,  with  a  40%  rate  of  anatomical  deteri-
oration  at  10  years  [6].  Late  anatomical  deterioration  —
or  restenosis  —  may  result  from  commissural  refusion  or
valve  rigidity  with  persistent  commissural  opening.  Distinc-
tion  between  these  two  features  is  of  crucial  importance,
as  a  new  PMC  may  be  attempted  in  case  of  restenosis  with
commissural  refusion  with  good  mid-term  results  in  selected
patients  [7],  whereas  PMC  is  of  no  use  in  case  of  valve  rigidity
with  persistence  of  commissural  opening.  Echocardiography
—  most  speciﬁcally  3D  echocardiography  —  plays  a  major
role  in  the  assessment  of  the  degree  of  commissural  opening
(Fig.  2).
Degenerative mitral stenosisDegenerative  MS  may  occur  in  elderly  people.  The  main
lesion  is  annular  calciﬁcation,  which  usually  has  few  or
no  hemodynamic  consequences,  unless  leaﬂet  thicken-
ing  and  calciﬁcation  are  associated.  Valve  thickening  and
s
e
a
cissural opening (A and B), a patient with a unilateral commissural
 and F). The arrows indicate the open commissures.
alciﬁcation  predominate  at  the  base  of  the  leaﬂets,
hereas  it  affects  predominantly  the  tips  in  rheumatic  MS.
n  addition,  there  is  no  commissural  fusion.  Evaluation  of
egenerative  MS  is  often  challenging  using  TTE  and  planime-
ry  is  not  always  feasible  or  reliable.  Three-dimensional  TEE
s  of  great  help  in  conﬁrming  the  absence  of  commissural
usion  and  measuring  the  valve  area  (Fig.  3).  In  our  experi-
nce,  measurement  of  the  valve  area  is  often  not  feasible
sing  2D  echocardiography,  whereas  it  is  much  easier  and
eliable  using  3D-TEE.
adiation-induced valvular mitral stenosis
adiation-induced  valvular  disease  is  uncommon  and  affects
pproximately  6—15%  of  patients  exposed  to  mediastinal
adiotherapy  [8].  On  average,  valve  lesions  are  diagnosed
1.5  years  after  radiation  therapy  and  symptoms  occur  5
ears  later  [9].  Valvular  regurgitations  are  more  common
nd  aortic  stenosis  is  the  main  reason  for  surgery.  MS  is  rare
nd  appears  many  years  after  the  original  exposure.  Typical
chocardiographic  features  involve  thickening  and  calciﬁ-
ation  of  both  aortic  and  mitral  valves.  Calciﬁcations  of  the
itral  aortic  membrane  have  been  reported  to  be  highly
uggestive  of  radiation-induced  lesions  [10]. Of  importance,
here  is  no  commissural  fusion  (complete  bilateral  commis-
ural  opening)  and  the  posterior  leaﬂet  is  mobile.  Again,  3D
chocardiography,  which  provides  direct  and  intuitive  visu-
lization  of  the  mitral  valve,  clearly  shows  the  absence  of
ommissural  fusion,  precluding  PMC  (Fig.  4).
114  L.  Krapf  et  al.
Figure 2. Restenosis due to valve rigidity several years after a percutaneous mitral commissurotomy in a patient with a rheumatic mitral
stenosis. Both commissures are open (arrows). (A) Two-dimensional transthoracic echocardiography. (B) Three-dimensional transthoracic
echocardiography.
Figure 3. Degenerative mitral stenosis. The annulus as well as the valve leaﬂets are thickened and calciﬁed. In contrast, both commissures
are open. Transthoracic echocardiography shows poor image deﬁnition (A), while three-dimensional transoesophageal echocardiography (B)
allows more accurate assessment of the degree of commissural opening and measurement of the mitral area (planimetry) (C).
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higure 4. Radiotherapy-induced mitral stenosis. Complete bilate
chocardiography and (B) three-dimensional transoesophageal echoongenital mitral stenosis
ongenital  MS  is  rare,  being  identiﬁed  in  0.6%  of  autopsied
earts  with  congenital  heart  disease  and  in  0.2—0.4%  of
c
d
o
lommissural opening (arrows) in (A) two-dimensional transthoracic
iography.linical  series.  It  is  usually  associated  with  other  car-
iac  defects.  It  may  result  from  any  or  combinations
f  supravalvular  ring  (complete  or  incomplete),  annu-
ar  hypoplasia,  leaﬂet  abnormalities  (leaﬂet  retraction,
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[Figure 5. Congenital mitral stenosis. Parachute-like congenital 
dimensional transthoracic echocardiography and (B) three-dimensio
commissural  fusion),  chordae  abnormalities  (shortness,
absence  of  chordae)  or  papillary  muscle  abnormalities
(single  papillary  muscle  inserting  into  the  leaﬂets,  i.e.
parachute  mitral  valve,  hypoplastic  or  arch-shaped  pap-
illary  muscle)  [11,12].  Echocardiography  shows  the  exact
function  and  anatomy  of  the  valve,  guiding  the  therapeutic
options  (Fig.  5).
Other  causes  are  exceptional,  inﬂammatory  diseases,
inﬁltrative  diseases,  carcinoid  disease  and  drug-induced
valve  disease  (benﬂuorex)  [13]. Leaﬂet  thickening  and
restriction  are  common  here,  while  commissures  are  seldom
fused.
Conclusion
A  comprehensive  assessment  of  the  anatomy  of  the  mitral
valve  is  crucial  for  the  appropriate  management  of  patients
with  MS.  The  assessment  of  the  degree  of  commissural  open-
ing  is  of  particular  interest  to  judge  the  feasibility  of  PMC.
Three-dimensional  echocardiography,  which  provides  direct
visualization  of  the  mitral  valve,  is  particularly  helpful  and
should  be  considered  as  part  of  the  systematic  echocardi-
ographic  examination,  especially  in  atypical  cases.  It  allows
a  comprehensive  assessment  of  the  degree  of  commissural
opening  and  an  assessment  of  the  MVA  in  difﬁcult  cases  or
for  teams  less  accustomed  to  evaluating  MS  patients.
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